(Q39275753)

10 September 2017

title

Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016. (English)

1 reference

10 September 2017

4

1 reference

10 September 2017

Yasushi Otani

1

1 reference

10 September 2017

Takashi Kijima

2

1 reference

10 September 2017

Satoshi Kohmo

3

1 reference

10 September 2017

Toshiyuki Minami

5

1 reference

10 September 2017

Izumi Nagatomo

6

1 reference

10 September 2017

Ryo Takahashi

7

1 reference

10 September 2017

Haruhiko Hirata

8

1 reference

10 September 2017

Mayumi Suzuki

9

1 reference

10 September 2017

Koji Inoue

10

1 reference

10 September 2017

Yoshito Takeda

11

1 reference

10 September 2017

Hiroshi Kida

12

1 reference

10 September 2017

Isao Tachibana

13

1 reference

10 September 2017

Nobutaka Fujii

14

1 reference

10 September 2017

Atsushi Kumanogoh

15

1 reference

10 September 2017

language of work or name

English

0 references

publication date

28 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

586

1 reference

10 September 2017

issue

20

1 reference

10 September 2017

page(s)

3639-3644

1 reference

Small-cell lung cancer: state of the art.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

Potential of CXCR4 antagonists for the treatment of metastatic lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.08.011

10.1016/J.FEBSLET.2012.08.011

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference